InsidersTradesSigma
Track the Abera Bioscience AB stock price and the full directors' dealings record of the company, a publicly traded company based in Finland. Shares are listed on the FI market, under the authority of FIN-FSA. Market capitalisation: €174.7m. The latest transaction was reported on 22 July 2026 (Purchase). Among the most active insiders: Mats Lundgren. All data is accessible without an account.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
Abera Bioscience AB is a company focused on the development of innovative vaccines. It is listed on the Stockholm Stock Exchange (XSTO).